Could Pharmacogenomics Improve Efficacy and Safety of Trastuzumab?
نویسندگان
چکیده
منابع مشابه
A Reachable Goal: Application of Pharmacogenomics Biomarkers to Improve Drug Efficacy and Safety
Ensuring drug efficacy and safety are unremitting challenges for drug manufacturers and public health organizations worldwide. It has been estimated that, when all of the drugs in the market used to treat common diseases are considered, only 25% to 60% of patients exhibit the expected pharmacological response [1], while a small portion of patients could develop adverse reactions (ADRs). ADRs ar...
متن کاملEfficacy of trastuzumab.
We read with interest the article by Adams et al. (1), which describes the efficacy of an yttrium-90-labeled anti-HER2 diabody in a mouse xenograft model of HER2-positive breast cancer. Women with HER2-positive breast cancer have a distinctly worse prognosis than those whose tumors do not overexpress HER2, with an increased rate of relapse, decreased disease-free survival, and increased mortali...
متن کاملa comparison of teachers and supervisors, with respect to teacher efficacy and reflection
supervisors play an undeniable role in training teachers, before starting their professional experience by preparing them, at the initial years of their teaching by checking their work within the proper framework, and later on during their teaching by assessing their progress. but surprisingly, exploring their attributes, professional demands, and qualifications has remained a neglected theme i...
15 صفحه اولEfficacy and safety of Trastuzumab added to standard treatments for HER2-positive metastatic breast cancer patients.
INTRODUCTION Trastuzumab, an HER2-targeting agents, has shown efficacy in metastatic HER2-positive breast cancer patients. Single-agent clinical trials have evaluated therapeutic regimens using trastuzumab for metastatic breast cancer patients. The aim of our study is to evaluate the efficacy and safety of trastuzumab in combination with chemotherapy or hormone therapy in HER2-positive metastat...
متن کاملEfficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
BACKGROUND The adjuvant short course 9-week trastuzumab combination therapy for human epidermal receptor 2 positive breast cancer patients may often be considered as a cost-effective and safe option and has important implications for the Indian subcontinent as well as other developing countries. However, such regimens of shorter duration trastuzumab therapy like FinHer, offered in view of econo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biochemistry & Pharmacology: Open Access
سال: 2015
ISSN: 2167-0501
DOI: 10.4172/2167-0501.1000e174